| Trial ID: | L1943 |
| Source ID: | NCT03356873
|
| Associated Drug: |
Vitamin D
|
| Title: |
Impact of Correction of Vitamin D Deficiency in Oxidative Stress in Patients With Prediabetes (VICOX)
|
| Acronym: |
VICOX
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Vitamin D Deficiency|Glucose Intolerance|Oxidative Stress|Insulin Resistance
|
| Interventions: |
DRUG: Vitamin D|OTHER: Placebo
|
| Outcome Measures: |
Primary: Change in anti-oxidant capacity measured in serum, Change in serum anti-oxidant capacity after one month, One month | Secondary: Change in homeostasis model assessment (HOMA) index measured in serum, Change in homeostasis model assessment (HOMA) index after one month, One month
|
| Sponsor/Collaborators: |
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
31
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-09-01
|
| Completion Date: |
2022-07-18
|
| Results First Posted: |
|
| Last Update Posted: |
2023-03-15
|
| Locations: |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, 14080, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT03356873
|
